Professional Documents
Culture Documents
September 9, 2022
REP-108
Muhammad Shahroz
Investment Analyst
muhammad.shahroz@akdsl.com
+92-111-253-111 Ext:603
Decent pricing power to ensure attractive payouts
We maintain our “over-weight” stance on the fertilizer sector due to its stable demand
AKD Universe Fertilizer sector Valuations dynamics, attractive dividend yield and reasonable pass-on ability.
TP Price Upside D/Y Stance The upcoming gas tariff hike of 42% and 82% for feed and fuel gas will increase the cost,
however we believe that the manufacturers have decent pricing power given the signifi-
EFERT 95 80.5 20.5% 17.7% Buy
cant discount between local and international urea prices.
FFC 124 102.0 21.8% 16.9% Buy
In federal budget FY23, GoP exempted the fertilizer sector from sales tax which stopped
FFBL 30 20.1 47.9% 4.9% Buy the pileup of sales tax refunds on manufacturers’ books, however this has resulted in an
increase in their cost.
FATIMA 41 36.6 12.9% 10.9% Buy
Heavy rains and flooding, especially in Sindh and Baluchistan have wreaked havoc in the
Source: PSX & AKD Research
region. As per initial reports, many standing crops have been destroyed by the natural
calamity. This might result in a period of slowdown in fertilizer offtakes, however we
expect offtakes to normalize in next few months.
Lately, news of the deregulation of fertilizer sector is making rounds. Deregulation of the
sector will increase the cost of fertilizer for farmers and will result in higher profits for
manufacturers but this deregulation will also expose the fertilizer companies to the
movements in international commodity prices.
Our top picks from the sector are FFC (TP: PkR124/sh, offering total return of ~37%) and
EFERT (TP: PkR95/sh, offering total return of ~35%).
Fertilizer Sector vs KSE100 Index Flood to hit fertilizer offtake in near term: The recent floods have wreaked havoc in the coun-
try affecting millions of people and damaging infrastructure. In addition, the flood has caused
32%
heavy damage to Kharif crops, especially cotton and rice. Furthermore, the floods might also
24%
result in delays in sowing of Rabi crops. As per our channel checks, standing crops of cotton and
different fruits & vegetables have been severely impacted by the floods. According to the chair-
16%
man of the Pakistan Cotton Ginners Association, around 40%-45% of the cotton crop has been
8%
damaged by the recent floods. Furthermore, the indirect impact of these floods in the form of
0% loss of soil nutrients will also hurt the sector. This could potentially hurt soil quality and will im-
-8% pact crop yields. However, once flood water recedes, we might see a jump in fertilizer offtakes
-16% as farmers try to replenish nutrients in flood hit areas. We believe that, fertilizer demand is also
-24%
expected to take a hit in the near term due to floods, where DAP sales have already started to
paint a gloomy picture. To note, DAP offtake is already down by ~18%YoY in 7MCY22, amid rec-
Feb-22
May-22
Mar-22
Apr-22
Jul-22
Oct-21
Sep-21
Nov-21
Dec-21
Jan-22
Jun-22
Aug-22
Sep-22
ord high prices. On urea front, we expect demand to take a hit in 3QCY22 but is expected to
KSE-100 Index Fertilizer Sector normalize in coming months like we witnessed in 2010. During the floods of 2010, which hit the
country in July, urea sales were lower by ~41%, 35%, and 15% against the 12 month moving
Source: PSX & AKD Research average in Aug, Sep and October, respectively.
1,000,000
800,000
600,000
400,000
200,000
0
AKD Securities Limited Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10
Urea DAP
However, sales witnessed a decent recovery in Nov and Dec increasing by 64% and 22% against
the 12 month moving average, respectively. One thing to note here is the difference between
the 2010 and current floods, the 2010 flood was river-flood caused by heavy rains resulting in
higher water levels. However, the impact of 2022 monsoon rain is far more widespread and will
take more time to recede, thus, affecting the fertility of land along with lower area availability
for next crop season.
Gas tariff hike, likely to be passed on: ECC approved increase in gas tariff across the board,
which is still awaiting a final nod from federal cabinet which has been pending for ~2 months.
The proposed increase in gas tariff for fertilizer manufacturers will take feed gas price from
PkR302/mmbtu to PkR430/mmbtu, up by ~42%, while fuel gas will increase to PkR1,857/mmbtu
from PkR1,023/mmtbu, up by ~82%. If passed on fully, the said increase in gas tariff will increase
per bag cost of urea production by PkR420/340/170/380 for FFC/EFERT/FFBL/FATIMA, respec-
tively. Local urea price stands at ~PkR2,250/bag which might see a jump of ~PkR400/bag post
increase in gas tariff, taking final price of urea to PkR2,650/bag. Urea manufacturers boast de-
cent pricing power in current scenario given the stable demand dynamics of the product and
significant gap between local & international urea price. However, recent flooding in the country
will restrict price pass on in the near term. To note, we have assumed price hike of PkR350/bag
for CY23 and a minimal increase going forward in our models.
Deregulation of sector: Fertilizer companies have been advocating for deregulation of the
sector for quite some time now and the work on the new fertilizer policy is underway. Key
points of the proposed fertilizer policy are uniform gas rate for all manufacturers, deregulation
of urea price, quota-based export mechanism, favorable policies to allow debottlenecking of
current facilities etc. Deregulation will result in removal of subsidy on gas resulting in higher cost
for manufacturers, however, fertilizer companies will then sell urea at import parity prices. This
will increase cost for farmers and effective subsidy mechanism will be needed for transparent
disbursement of the subsidy. On the flip side, this will not only increase the profitability of ferti-
lizer companies, but also result in higher tax collection for the Gov’t. However, this will expose
the industry to swings in international commodity prices.
2,000 2,000
0 0
Mar-22
Mar-21
May-21
Jul-21
May-22
Jul-22
Jan-21
Sep-21
Nov-21
Jan-22
May-21
May-22
Mar-21
Jul-21
Mar-22
Jul-22
Nov-21
Jan-21
Sep-21
Jan-22
CY16
CY17
CY18
CY19
CY20
CY21
regulatory changes.
1Yr High (PkR) 95.5 EPS (PkR) 15.8 12.3 19.1 18.0 15.8
1Yr Low (PkR) 58.7 EPS Growth 16.3% -22.0% 54.8% -5.9% -11.8%
PER (x) 5.1 6.5 4.2 4.5 5.1
3M Avg Turnover '000 1,619.9 BVS (PkR) 35.3 34.6 35.4 36.4 37.2
1 Yr Avg Turnover '000 1,807.0
P/BVS(x) 2.30 2.33 2.27 2.21 2.16
3M Avg DT Value (PkR'000) 136,776 ROE 44.8% 35.6% 53.9% 49.4% 42.6%
3M Avg DT Value (US$'000) 606.8 ROA 15.9% 12.3% 19.0% 17.6% 15.3%
DPS (PkR) 16.5 13.0 18.3 17.0 15.0
1Yr Avg DT Value (PkR'000) 140,503.4
Dividend yield 20.6% 16.1% 22.7% 21.1% 18.6%
1Yr Avg DT Value (US$'000) 623.3
Payout Ratio 104.4% 105.5% 95.6% 94.7% 94.7%
Source: PSX & AKD Research
Income Statement
(PkRmn) CY21 CY22F CY23F CY24F CY25F
Net sales 132,363 161,876 195,187 188,591 173,211
Cost of sales 88,289 115,202 140,140 136,509 125,616
EFERT vs KSE100 Index
Gross profit 44,074 46,673 55,048 52,082 47,595
60% Financial charges 1,603 1,963 1,786 991 684
50% Profit before tax 29,890 31,114 38,032 35,794 31,566
40% Taxation 8,798 14,657 12,551 11,812 10,417
30%
Net Profit 21,092 16,457 25,482 23,982 21,150
20%
10%
0% Balance Sheet
-10% (PkRmn) CY21 CY22F CY23F CY24F CY25F
-20%
Current assets 54,425 52,787 50,951 52,682 53,715
Mar-22
May-22
Apr-22
Jul-22
Jun-22
Oct-21
Jan-22
Feb-22
Sep-21
Nov-21
Dec-21
Aug-22
Sep-22
25.0 20.0
20.0 16.0
15.0 12.0
10.0 8.0
5.0 4.0
0.0 0.0
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
60% 20%
19.0%
53.9%
44.8%
15.9%
44% 16% 15.3%
42.6%
36% 14%
35.6%
28% 12%
12.3%
20% 10%
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
25%
60%
20% 50%
40%
15%
30%
10%
20%
5%
10%
0% 0%
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
AKD RESEARCH
Balance Sheet
(In PkRmn) 2QCY21 3QCY21 4QCY21 1QCY22 2QCY22
Long Term Assets 70,676 74,572 78,394 80,243 81,436
Current Assets 54,175 52,564 54,425 52,993 60,526
Total Assets 124,851 127,136 132,819 133,236 141,962
Long Term Liabilities 31,759 32,957 30,924 31,505 27,272
Current Liabilities 46,534 48,551 54,808 55,809 76,210
Total Liabilities 78,293 81,508 85,732 87,314 103,482
Share Holders' Equity 46,557 45,628 47,087 45,922 38,479
Total Liabilities & Equity 124,850 127,136 132,819 133,236 141,961
YoY Assets Growth
Cash flow Statement
(In PkRmn) 2QCY21 3QCY21 4QCY21 1QCY22 2QCY22
CF from operations 2,065 9,587 5,024 15,998 7,327
CF from investing activities 23,250 18,450 (2,422) (2,134) (5,174)
CF from financing activities (15,283) (22,124) (1,264) (10,920) (15,855)
Net chg. In cash & equiv. 10,031 5,913 1,338 2,944 (13,702)
Cash & Equiv. At beg. of the year 5,126 5,126 11,039 12,377 12,377
Cash & Equiv. At end of the period 15,157 11,039 12,377 15,321 (1,325)
0% Balance Sheet
-10% (PkRmn) CY21 CY22F CY23F CY24F CY25F
-20% Current assets 126,270 126,346 127,450 126,389 126,023
Mar-22
May-22
Apr-22
Jul-22
Oct-21
Feb-22
Nov-21
Dec-21
Sep-21
Jan-22
Jun-22
Aug-22
Sep-22
30.0 25.0
24.0 20.0
18.0 15.0
12.0 10.0
6.0 5.0
0.0 0.0
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
60.0% 17.0%
50.0%
46.1% 45.5% 46.1% 13.0%
45.0% 11.8%
10.9%
11.0%
40.0%
35.0% 9.0%
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
150%
35%
28% 120%
21% 90%
14% 60%
7% 30%
0% 0%
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
AKD RESEARCH
Balance Sheet
(In PkRmn) 2QCY21 3QCY21 4QCY21 1QCY22 2QCY22
Long Term Assets 62,560 73,969 74,737 76,078 77,794
Current Assets 121,137 123,678 126,270 118,769 151,872
Total Assets 183,696 197,647 201,007 194,847 229,667
Long Term Liabilities 39,702 48,289 41,323 38,283 32,070
Current Liabilities 100,837 103,079 112,169 108,785 151,209
Total Liabilities 140,539 151,369 153,492 147,068 183,280
Share Holders' Equity 43,158 46,278 47,514 47,779 46,387
Total Liabilities & Equity 183,696 197,647 201,007 194,847 229,667
5%
Taxation 5,134 8,214 4,437 3,936 3,239
0% Net Profit 6,391 9,120 10,511 9,494 8,143
-5%
Apr-22
Aug-22
Sep-21
Mar-22
May-22
Sep-22
Feb-22
Jul-22
Nov-21
Dec-21
Jan-22
Jun-22
10.0 3.0
8.0 2.4
6.0 1.8
4.0 1.2
2.0 0.6
0.0 0.0
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
8.0% 7.8%
30.0% 28.5% 7.6%
7.1%
25.0% 7.0%
21.7%
15.0% 5.0%
10.0% 4.0%
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
30% 200%
24% 160%
18% 120%
12% 80%
6% 40%
0% 0%
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Balance Sheet
(In PkRmn) 2QCY21 3QCY21 4QCY21 1QCY22 2QCY22
Long Term Assets 42,458 38,373 39,803 40,379 40,251
Current Assets 57,041 56,048 75,407 79,203 99,874
Total Assets 99,498 94,421 115,210 119,582 140,126
Long Term Liabilities 27,239 26,094 25,696 23,454 20,586
Current Liabilities 54,310 48,103 69,083 74,071 95,699
Total Liabilities 81,549 74,197 94,779 97,525 116,285
Share Holders' Equity 17,949 20,224 20,431 22,058 23,841
Total Liabilities & Equity 99,498 94,421 115,210 119,582 140,126
Cashflow Statement
(In PkRmn) 2QCY21 3QCY21 4QCY21 1QCY22 2QCY22
CF from operations (4,847) 2,441 22,300 (20,272) (19,443)
CF from investing activities 766 7,365 (3,057) (587) 8,115
CF from financing activities (3,700) (5,712) (3,477) (965) (2,379)
Net chg. In cash & equiv. (7,780) 4,094 15,766 (21,823) (13,707)
Cash & Equiv. At beg. of the year 13,676 13,676 13,676 29,442 29,442
Cash & Equiv. At end of the period 5,896 17,770 29,442 7,619 15,735
1Yr High (PkR) 41.3 BVS (PkR) 47.7 52.4 62.5 67.0 67.1
1Yr Low (PkR) 26.1 P/BVS(x) 0.66 0.70 0.59 0.55 0.55
ROE 18.4% 15.5% 22.0% 17.0% 12.0%
3M Avg Turnover '000 147.2
ROA 10.0% 9.3% 14.1% 11.4% 8.3%
1 Yr Avg Turnover '000 445.4
DPS (PkR) 3.5 4.0 6.7 7.8 5.9
3M Avg DT Value (PkR'000) 5,502 Dividend yield 9.6% 10.9% 18.3% 21.2% 16.0%
3M Avg DT Value (US$'000) 24.4
Payout Ratio 39.8% 49.2% 50.0% 70.1% 75.1%
1Yr Avg DT Value (PkR'000) 14,802.9
1Yr Avg DT Value (US$'000) 65.7 Income Statement
Source: PSX & AKD Research (PkRmn) CY21 CY22F CY23F CY24F CY25F
Net sales 112,488 136,350 155,856 143,785 125,738
Cost of sales 69,404 82,592 94,632 89,783 81,832
Gross profit 43,084 53,758 61,224 54,002 43,906
Financial charges 2,007 2,135 1,524 1,246 1,154
Other Expenses 5,154 4,886 3,713 3,055 2,155
FATIMA vs KSE100 Index Other Income 1,210 1,276 1,556 1,491 1,445
Profit before tax 28,186 35,596 41,960 34,660 24,400
60%
Taxation 9,711 18,516 13,847 11,438 8,052
50%
Net Profit 18,475 17,080 28,113 23,222 16,348
40%
30%
-10%
Current assets 71,774 70,179 90,936 94,994 89,344
-20% Long term assets 113,120 112,557 112,115 112,789 113,576
Jan-22
Mar-22
Apr-22
May-22
Jun-22
Jul-22
Oct-21
Feb-22
Sep-21
Nov-21
Dec-21
Aug-22
Sep-22
15.0 10.0
12.0 8.0
9.0 6.0
6.0 4.0
3.0 2.0
0.0 0.0
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
21.0% 13.0%
18.4% 11.4%
17.0%
17.0% 11.0%
15.5% 10.0%
9.0% 7.0%
5.0% 5.0%
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
8%
15%
12%
6%
9%
4%
6%
2%
3%
0% 0%
CY21 CY22F CY23F CY24F CY25F CY21 CY22F CY23F CY24F CY25F
Source: Company Report & AKD Research Source: Company Report & AKD Research
AKD RESEARCH
Income Statement
(In PkRmn) 2QCY21 3QCY21 4QCY21 1QCY22 2QCY22
Net Sales 22,430 29,462 38,993 29,114 33,170
COGS 14,653 16,881 25,530 16,863 17,117
Gross Profit 7,776 12,581 13,463 12,251 16,052
Operating Exp 1,956 2,585 1,996 2,561 3,251
Operating Profit 5,820 9,996 11,467 9,690 12,801
Other Income 1,495 347 -736 348 563
Other Charges 1,768 1,739 1,148 1,368 2,014
Financial Charges 385 565 514 417 758
NPBT 5,162 8,039 9,068 8,253 10,593
Taxation 1,541 3,262 2,764 2,563 10,426
NPAT 3,621 4,777 6,304 5,690 167
Balance Sheet
(In PkRmn) 2QCY21 3QCY21 4QCY21 1QCY22 2QCY22
Long Term Assets 115,385 113,958 113,120 115,490 116,007
Current Assets 56,062 59,966 71,774 73,440 80,876
Total Assets 171,447 173,924 184,893 188,930 196,883
Long Term Liabilities 28,336 30,207 30,307 30,493 36,652
Current Liabilities 51,944 47,773 54,323 52,484 61,534
Total Liabilities 80,279 77,980 84,630 82,977 98,187
Share Holders' Equity 91,167 95,944 100,263 105,953 98,697
Total Liabilities & Equity 171,447 173,924 184,893 188,930 196,883
Equity & Asset return based methodologies (EVA, Residual Income etc.)
Analyst Certification of Independence
The analysts hereby certify that their views about the companies and their securities discussed in this report are accurately expressed and that they have not re-
ceived and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report.
The research analysts, strategists or research associates principally having received compensation responsible for the preparation of this AKDS research report
based upon various factors including quality of research, investor client feedback, stock picking, competitive factors and firm revenues.
Disclosure of Interest Area
AKDS and the authoring analyst do not have any interest in any companies recommended in this research report irrespective of the fact that AKD Securities Limited
may have, within the last three years, served as manager or co-manager of a public offering of securities for, or currently may make a primary market in issues of,
any or all of the entities mentioned in this report or may be providing, or have provided within the previous 12 months, significant advice or investment services in
relation to the investment concerned or a related investment.
Regional Disclosures (Outside Pakistan)
The information provided in this report and the report itself is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where
such distribution or use would be contrary to law or regulation or which would subject AKDS or its affiliates to any registration or licensing requirements within such
jurisdiction or country.
Furthermore, all copyrights, patents, intellectual and other property in the information contained in this report are held by AKDS. No rights of any kind are licensed
or assigned or shall otherwise pass to persons accessing this information. You may print copies of the report or information contained within herein for your own
private non-commercial use only, provided that you do not change any copyright, trade mark or other proprietary notices. All other copying, reproducing, trans-
mitting, distributing or displaying of material in this report (by any means and in whole or in part) is prohibited.
For the United States
Compliance Notice.
This research report prepared by AKD Securities Limited is distributed in the United States to Major US Institutional Investors (as defined in Rule 15a-6 under the
Securities Exchange Act of 1934, as amended) only by Decker & Co, LLC, a broker-dealer registered in the US (registered under Section 15 of Securities Exchange Act
of 1934, as amended). All responsibility for the distribution of this report by Decker & Co, LLC in the US shall be borne by Decker & Co, LLC. All resulting transactions
by a US person or entity should be effected through a registered broker-dealer in the US. This report is not directed at you if AKD Securities Limited or Decker & Co,
LLC is prohibited or restricted by any legislation or regulation in any jurisdiction from making it available to you. You should satisfy yourself before reading it that
Decker & Co, LLC and AKD Securities Limited are permitted to provide research material concerning investment to you under relevant applicable legislations and
regulations.